Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700)
Publication
, Journal Article
Maclean, KH; Dorsey, FC; Cleveland, JL; Kastan, MB
Published in: Journal of Clinical Investigation
April 1, 2008
Duke Scholars
Published In
Journal of Clinical Investigation
DOI
EISSN
1558-8238
ISSN
0021-9738
Publication Date
April 1, 2008
Volume
118
Issue
4
Start / End Page
1584
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008). Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700). Journal of Clinical Investigation, 118(4), 1584. https://doi.org/10.1172/JCI33700C1
Maclean, K. H., F. C. Dorsey, J. L. Cleveland, and M. B. Kastan. “Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700).” Journal of Clinical Investigation 118, no. 4 (April 1, 2008): 1584. https://doi.org/10.1172/JCI33700C1.
Maclean KH, Dorsey FC, Cleveland JL, Kastan MB. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700). Journal of Clinical Investigation. 2008 Apr 1;118(4):1584.
Maclean, K. H., et al. “Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700).” Journal of Clinical Investigation, vol. 118, no. 4, Apr. 2008, p. 1584. Scopus, doi:10.1172/JCI33700C1.
Maclean KH, Dorsey FC, Cleveland JL, Kastan MB. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700). Journal of Clinical Investigation. 2008 Apr 1;118(4):1584.
Published In
Journal of Clinical Investigation
DOI
EISSN
1558-8238
ISSN
0021-9738
Publication Date
April 1, 2008
Volume
118
Issue
4
Start / End Page
1584
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences